We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NA:NASDAQNano Labs Ltd Analysis

Data as of 2026-04-19 - not real-time

$2.77

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Nano Labs Ltd (NA) is trading at $2.77, barely above its 30‑day support of $2.70 and well below the 20‑day resistance of $3.37, indicating limited upside in the near term. The stock shows a bearish technical stance with an RSI of 38.7, a MACD histogram in negative territory and a “bearish” MACD signal, while volume is increasing, suggesting sellers are still in control. Volatility is extreme at over 50% (30‑day) and beta exceeds 1.2, pointing to a highly volatile equity that moves more than the market.
Fundamentally, NA appears cheap with a trailing P/E of 2.77 versus an industry average of 36.69 and a P/B of 0.58, but this apparent discount masks serious weaknesses: gross margin is –26%, operating margin –195%, and the company generated negative operating cash flow of $108 M and free cash flow of $177 M. Debt is massive ($235 M) with a debt‑to‑equity ratio above 30, and the balance sheet shows a max drawdown of –81%. Recent news cites a “significant net income improvement” and a share‑buyback program, yet cash reserves remain modest at $37 M, underscoring the fragility of the turnaround. Investors should weigh the low valuation against the deep financial distress and sector‑specific regulatory headwinds in China’s semiconductor space.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish momentum (RSI < 40, MACD bearish)
  • Price hovering just above support with limited upside
  • High volatility and beta amplifying downside risk

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential upside from announced share buyback
  • Continued cash burn and heavy debt load
  • Unclear path to sustainable profitability

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Structural financial weakness (negative margins, large debt)
  • Exposure to Chinese semiconductor regulatory constraints
  • Extreme price volatility and lack of dividend

Key Metrics & Analysis

Financial Health

Revenue Growth18.10%
Profit Margin501.60%
P/E Ratio2.8
ROE25.87%
ROA-5.37%
Debt/Equity31.79
P/B Ratio0.6
Op. Cash Flow$-108268896
Free Cash Flow$-176946048
Industry P/E36.7

Technical Analysis

TrendBearish
RSI38.7
Support$2.70
Resistance$3.37
MA 20$2.97
MA 50$3.00
MA 200$4.39
MACDBearish
VolumeIncreasing
Fear & Greed Index90.21

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta1.27
Volatility50.34%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.